Further analysis of the clinical outcome data showed that higher expression levels of these DDR genes in high-grade and/or low-grade gliomas are significantly associated with decreased survival (Fig. 6C and Supplementary Fig. S6). This evidence concerns the gene DDR1 and glioma.